The COG Review: Building Better Clinical Studies
- Business
- Health & Fitness · Medicine
- Science · Life Sciences
Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
This podcast is specifically designed for biopharma sponsors and CRO executives who are interested in clinical trial outsourcing. The COG Review delivers clinical operations best practices from Clinical Outsourcing Group conferences across the UK, Europe, and North America. Each 25-minute episode provides actionable insights on CRO selection, vendor management, clinical trial budget optimization, and study design from pharmaceutical and biotech leaders. Learn clinical trial technology strategies, AI integration, and sponsor-CRO relationship best practices from industry experts at COG UK, COG Europe, COG Bay Area, and COG CRO Summit. Essential listening for clinical operations professionals, biotech CMOs, and clinical development executives...
Also on
Recent episodes
- Master Protocols in Rare Disease: Practical Approaches to Basket and Umbrella Trial Design for Clinical Study Optimization with Nerissa Kreher
- Flexibility by Design: Rethinking hybrid models for today’s trials with Bianca Fajardo
- How To Build Trust and Engage Patients in African Clinical Trials with Dr Sam Mbunya
- Direct Clinical Trial Management: Practical Approaches to CRO Selection and Clinical Outsourcing for Lean Biotech Teams with Antonio Bermejo Gomez
- Strategic CRO Selection & Vendor Partnerships: Real-World Approaches for Emerging Biopharma
- The State of Clinical Trial Outsourcing in the UK: Optimizing Site Selection, Resources, and Performance
- Designing Clinical Trials to Avoid Historical Failures in HR-MDS with Joab Wiliamson
- The Future of Risk Based Quality Management for Early Phase Studies with Duncan Hall
- Leveraging Key Opinion Leaders in Clinical Research Strategy and Execution With Thierry Schulmann
- Navigating Biotech’s First-in-Human Trial in Rare Disease With Jurate Lasiene
